134 related articles for article (PubMed ID: 15755067)
21. [Concomitant chemo-radiotherapy for locoregionally advanced nasopharygeal carcinoma].
Tian Y; Chua DT; Sham JS
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):429-31. PubMed ID: 16188131
[TBL] [Abstract][Full Text] [Related]
22. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
Johnson FM; Garden AS; Palmer JL; Shin DM; Morrison W; Papadimitrakopoulou V; Khuri F; Clayman G; Goepfert H; Ang KK; Hong WK; Glisson BS
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):717-24. PubMed ID: 16199307
[TBL] [Abstract][Full Text] [Related]
24. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
25. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma.
Kwong DL; Sham JS; Leung LH; Cheng AC; Ng WM; Kwong PW; Lui WM; Yau CC; Wu PM; Wei W; Au G
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):374-81. PubMed ID: 16213105
[TBL] [Abstract][Full Text] [Related]
26. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.
Urba S; Wolf G; Eisbruch A; Worden F; Lee J; Bradford C; Teknos T; Chepeha D; Prince M; Hogikyan N; Taylor J
J Clin Oncol; 2006 Feb; 24(4):593-8. PubMed ID: 16380415
[TBL] [Abstract][Full Text] [Related]
27. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
28. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma.
Atasoy BM; Dane F; Yumuk PF; Akgün Z; Turhal NS; Abacioğlu U; Sengöz M
J BUON; 2008; 13(1):43-50. PubMed ID: 18404785
[TBL] [Abstract][Full Text] [Related]
29. A preliminary result of concurrent chemoradiation with weekly cisplatin in elderly nasopharyngeal carcinoma patients.
Ho HC; Su YC; Lee MS; Hsiao SH; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2008 Aug; 128(8):930-5. PubMed ID: 18607921
[TBL] [Abstract][Full Text] [Related]
30. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
Chen M; Lin S; Zheng W
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
[TBL] [Abstract][Full Text] [Related]
32. High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.
Nakamura RA; Novaes PE; Antoneli CB; Fogaroli RC; Pellizzon AC; Ferrigno R; Maia MA; Salvajoli JV; Pereira AJ; Nishimoto IN
Cancer; 2005 Aug; 104(3):525-31. PubMed ID: 15986481
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of locally advanced nasopharyngeal cancer with concurrent chemoradiotherapy.
Yarney J; Vanderpuye V; Kitcher ED
West Afr J Med; 2008 Apr; 27(2):65-8. PubMed ID: 19025016
[TBL] [Abstract][Full Text] [Related]
34. A multi-institutional survey of the effectiveness of chemotherapy combined with radiotherapy for patients with nasopharyngeal carcinoma.
Kawashima M; Fuwa N; Myojin M; Nakamura K; Toita T; Saijo S; Hayashi N; Ohnishi H; Shikama N; Kano M; Yamamoto M
Jpn J Clin Oncol; 2004 Oct; 34(10):569-83. PubMed ID: 15591454
[TBL] [Abstract][Full Text] [Related]
35. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
[TBL] [Abstract][Full Text] [Related]
36. Concurrent chemoradiotherapy with cyclophosphamide, pirarubicin, and cisplatin for patients with locally advanced salivary gland carcinoma.
Katori H; Tsukuda M
Acta Otolaryngol; 2006 Dec; 126(12):1309-14. PubMed ID: 17101593
[TBL] [Abstract][Full Text] [Related]
37. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P
Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
[TBL] [Abstract][Full Text] [Related]
38. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
39. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.
Ma J; Mai HQ; Hong MH; Min HQ; Mao ZD; Cui NJ; Lu TX; Mo HY
J Clin Oncol; 2001 Mar; 19(5):1350-7. PubMed ID: 11230478
[TBL] [Abstract][Full Text] [Related]
40. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
de Crevoisier R; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
